Cutaneous lymphoma
Information
- Disease name
- Cutaneous lymphoma
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00400556 | Completed | Phase 1 | ATRA Plus G-CSF for Mobilization of Hematopoietic Stem and Progenitor Cells | March 2005 | May 2005 |
| NCT01396070 | Completed | Phase 2 | Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides With Variable CD30 Expression Level | May 2011 | May 2016 |
| NCT01902225 | Completed | Phase 1 | Phase I Dose-finding and Preliminary Efficacy Study of the Istodax® in Combination With Doxil® for the Treatment of Adults With Relapsed or Refractory Cutaneous T-cell Lymphoma | March 4, 2014 | April 11, 2020 |
| NCT03458117 | Completed | Phase 1 | T-VEC in Non-melanoma Skin Cancer | April 19, 2018 | March 15, 2022 |
| NCT04520529 | Not yet recruiting | N/A | Identification of Prognostic Factors and New Therapeutic Targets in Cutaneous Lymphomas | September 30, 2020 | September 30, 2050 |
| NCT04670874 | Recruiting | Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29 | August 17, 2023 | January 24, 2034 | |
| NCT03602157 | Recruiting | Phase 1 | Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL | December 12, 2018 | September 30, 2041 |
| NCT01187446 | Terminated | Phase 1/Phase 2 | Low-dose (12 Gy) TSEBT+Vorinostat Versus Low-dose TSEBT Monotherapy in Mycosis Fungoides | December 2010 | February 2014 |
| NCT01556828 | Terminated | Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing | June 2011 | June 2014 |